Here’s just one of many reasons why it’s bad that Donald Trump and his cabinet are busy removing corporate regulations.
This is how far pharmaceutical companies will go to push their expensive drugs on the public. Insys Therapeutics fabricated medical records, lied to insurers, and paid off doctors to boost the sales of an expensive new pain killer intended for cancer patients, according to a congressional investigation. The drug — Subsys, a powerful and highly addictive opioid — was prescribed to thousands of people who didn’t have cancer. At least one person died from a Subsys overdose. Federal prosecutors have brought charges against several of the company’s executives.
These tactics are extreme, but not that different from common practices in the pharmaceutical industry. Drug companies dole out hundreds of millions of dollars to doctors in the form of speaking fees, pay off their competitors to delay the release of cheaper drugs, and repackage generic medication to charge patients through the nose. The result is higher prescription drug costs than any other advanced nation. We must stop these greedy companies from profiteering off the sick and vulnerable.
What do you think?